Interesting People mailing list archives
SEC Gave "Preferential Treatment" to Wall Street CEO
From: David Farber <dave () farber net>
Date: Wed, 8 Oct 2008 09:02:19 -0400
Begin forwarded message: From: "lynn" <lynn () ecgincc com> Date: October 8, 2008 8:48:26 AM EDT To: dave () farber net Subject: Report: SEC Gave "Preferential Treatment" to Wall Street CEO http://abcnews.go.com/Blotter/story?id=5970263&page=1 Report: SEC Gave "Preferential Treatment" to Wall Street CEO The SEC gave "preferential treatment" to Wall Street executive John Mack during an insider trading investigation three years ago because Mack was about to become CEO of the Morgan Stanley investment banking firm, the SEC's inspector general concluded in a report obtained by ABC News.Many say the Securities and Exchange Commission didn't enforce Wall Street
Laws. The report recommended disciplinary action against the SEC's chief of enforcement, Linda Thomson, and said the firing of an SEC lawyer was"connected" to his persistent attempts to take Mack's testimony. Read the
report's conclusion and recommendations here."There's a culture at the SEC that they're not willing to take on the big
boys, whether big economically or big politically," said Sen. Charles Grassley (R-IA) who requested the inspector general's investigation.It is a damning indictment of the SEC at a time when it is being asked to
step up its enforcement action against Wall Street. Related FBI, SEC, Federal Reserve 'Failed to Connect the Dots' to Wall Street WATCH: Warning Signs at Lehman? "They ought to be able to challenge anybody regardless of their economic might or regardless of their political might," said Sen. Grassley.Grassley asked for the investigation after a SEC lawyer who sought to take
Mack's testimony, Gary Aguirre, was fired. snip ------------------------------------------- Archives: https://www.listbox.com/member/archive/247/=now RSS Feed: https://www.listbox.com/member/archive/rss/247/ Powered by Listbox: http://www.listbox.com
Current thread:
- SEC Gave "Preferential Treatment" to Wall Street CEO David Farber (Oct 08)